PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,100.00
Bid: 1,101.50
Ask: 1,102.50
Change: -40.00 (-3.51%)
Spread: 1.00 (0.091%)
Open: 1,142.00
High: 1,160.50
Low: 1,093.50
Prev. Close: 1,140.00
BRBY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

14 Sep 2020 09:03

RNS Number : 8828Y
J.P. Morgan Securities PLC.
14 September 2020
 

14 September 2020

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Burberry Group plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Burberry Group plc

Guarantor (if any):

N/A

Aggregate nominal amount:

GBP 300mm

Description:

5Y GBP FXD RegS Bearer Senior Unsecured Sustainability Bonds

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: GPB 100,000 x GBP 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

HSBC (Stabilisation Manager(s))

NatWest Markets (Stabilisation Manager(s))

Societe Generale (Stabilisation Manager(s))

Lloyds (Stabilisation Manager(s))

MUFG (Stabilisation Manager(s))

Stabilisation period expected to start on:

14 September 2020

Stabilisation period expected to end no later than:

14 October 2020

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAPNLFEAEEEA
Date   Source Headline
26th Sep 20197:00 amRNSTransaction in Own Shares
25th Sep 20197:00 amRNSTransaction in Own Shares
24th Sep 20197:00 amRNSTransaction in Own Shares
23rd Sep 20197:00 amRNSTransaction in Own Shares
20th Sep 201910:17 amRNSBoard Changes
20th Sep 20197:00 amRNSTransaction in Own Shares
19th Sep 20197:00 amRNSTransaction in Own Shares
18th Sep 20197:00 amRNSTransaction in Own Shares
17th Sep 20197:00 amRNSTransaction in Own Shares
16th Sep 20197:00 amRNSTransaction in Own Shares
13th Sep 20197:00 amRNSTransaction in Own Shares
12th Sep 20197:00 amRNSTransaction in Own Shares
11th Sep 20197:00 amRNSTransaction in Own Shares
10th Sep 20197:00 amRNSTransaction in Own Shares
6th Sep 20196:05 pmRNSShare Repurchase Programme
2nd Sep 20192:59 pmRNSBlock listing Interim Review
2nd Sep 201911:58 amRNSTotal Voting Rights
8th Aug 20195:31 pmRNSDirector/PDMR Shareholding
6th Aug 20194:35 pmRNSDirector/PDMR Shareholding
6th Aug 201912:50 pmRNSDirector/PDMR Shareholding
1st Aug 201912:09 pmRNSTotal Voting Rights
1st Aug 201910:32 amRNSDirector/PDMR Shareholding
17th Jul 201912:48 pmRNSResult of AGM
16th Jul 20197:00 amRNSFirst Quarter Trading Update
1st Jul 20191:07 pmRNSTotal Voting Rights
24th Jun 201910:15 amRNSDirector/PDMR Shareholding
19th Jun 201911:50 amRNSDirector/PDMR Shareholding
5th Jun 20191:04 pmRNSAnnual Financial Report
3rd Jun 201910:20 amRNSTotal Voting Rights
20th May 20192:30 pmRNSDirector/PDMR Shareholding
16th May 20191:30 pmRNSBoard Changes
16th May 20197:00 amRNSPreliminary Results
1st May 201912:37 pmRNSTotal Voting Rights
1st Apr 201911:33 amRNSTotal Voting Rights
1st Mar 20194:15 pmRNSBlock listing Interim Review
1st Mar 201911:28 amRNSTotal Voting Rights
6th Feb 20194:55 pmRNSBoard Committee Changes
5th Feb 20192:45 pmRNSDirector/PDMR Shareholding
1st Feb 20193:34 pmRNSTotal Voting Rights
28th Jan 20196:07 pmRNSDirector/PDMR Shareholding
28th Jan 201910:00 amRNSDirector/PDMR Shareholding
23rd Jan 20197:00 amRNSThird Quarter Trading Update
2nd Jan 201911:32 amRNSTotal Voting Rights
6th Dec 20183:30 pmRNSDirector/PDMR Shareholding
3rd Dec 20184:10 pmRNSTotal Voting Rights
12th Nov 20183:00 pmRNSTreasury Shares Cancellation
8th Nov 201810:00 amRNSBoard Committee Changes
8th Nov 20187:00 amRNSHalf-year Report
25th Oct 20189:46 amRNSDirector Declaration
1st Oct 20181:32 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.